Morgan Stanley Biolife Solutions Inc Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Biolife Solutions Inc stock. As of the latest transaction made, Morgan Stanley holds 393,330 shares of BLFS stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

393,330

Previous 292,135 34.64%

Holding current value

$10.8 Million

Previous $6.26 Million 57.27%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$19.19 - $26.52 $1.94 Million - $2.68 Million	101,195 Added 34.64%	393,330 $9.85 Million
Q2 2024 Oct 17, 2024	SELL	$15.14 - $22.99 $1.57 Million - $2.39 Million	-103,893 Reduced 26.23%	292,135 $6.26 Million
Q2 2024 Aug 14, 2024	SELL	$15.14 - $22.99 $1.57 Million - $2.39 Million	-103,893 Reduced 26.23%	292,135 $6.26 Million
Q1 2024 Oct 17, 2024	BUY	$15.35 - $18.82 $1.59 Million - $1.96 Million	103,893 Added 35.56%	396,028 $7.35 Million
Q1 2024 Aug 16, 2024	BUY	$15.35 - $18.82 $698,440 - $856,328	45,501 Added 12.98%	396,028 $7.35 Million
Q1 2024 May 15, 2024	BUY	$15.35 - $18.82 $698,440 - $856,328	45,501 Added 12.98%	396,028 $7.35 Million
Q4 2023 Aug 16, 2024	BUY	$8.99 - $16.86 $524,944 - $984,489	58,392 Added 19.99%	350,527 $5.7 Million
Q4 2023 Feb 13, 2024	SELL	$8.99 - $16.86 $260,386 - $488,333	-28,964 Reduced 7.63%	350,527 $5.7 Million
Q3 2023 Nov 15, 2023	SELL	$10.81 - $22.96 $137,297 - $291,614	-12,701 Reduced 3.24%	379,491 $5.24 Million
Q2 2023 Aug 14, 2023	SELL	$17.19 - $24.34 $430,970 - $610,228	-25,071 Reduced 6.01%	392,192 $8.67 Million
Q1 2023 May 15, 2023	BUY	$17.67 - $26.07 $1.43 Million - $2.12 Million	81,191 Added 24.16%	417,263 $9.08 Million
Q4 2022 Feb 14, 2023	SELL	$16.95 - $25.07 $2.65 Million - $3.92 Million	-156,504 Reduced 31.77%	336,072 $6.12 Million
Q3 2022 Nov 14, 2022	BUY	$14.64 - $26.7 $1.44 Million - $2.62 Million	98,052 Added 24.85%	492,576 $11.2 Million
Q2 2022 Oct 27, 2022	BUY	$10.54 - $24.2 $1.9 Million - $4.36 Million	180,032 Added 83.93%	394,524 $5.45 Million
Q2 2022 Aug 15, 2022	BUY	$10.54 - $24.2 $1.9 Million - $4.36 Million	180,032 Added 83.93%	394,524 $5.45 Million
Q1 2022 Oct 27, 2022	SELL	$20.81 - $37.29 $3.75 Million - $6.71 Million	-180,032 Reduced 45.63%	214,492 $4.88 Million
Q1 2022 May 13, 2022	BUY	$20.81 - $37.29 $1.19 Million - $2.14 Million	57,367 Added 36.51%	214,492 $4.88 Million
Q4 2021 Feb 14, 2022	SELL	$32.99 - $58.55 $1.35 Million - $2.39 Million	-40,838 Reduced 20.63%	157,125 $5.86 Million
Q3 2021 Nov 15, 2021	BUY	$42.03 - $60.5 $8.32 Million - $12 Million	197,963 New	197,963 $8.38 Million

Others Institutions Holding BLFS

# of Institutions

198

Shares Held

44.9M

Call Options Held

8.2K

Put Options Held

View Full List

About BIOLIFE SOLUTIONS INC

Ticker BLFS
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 42,684,400
Market Cap $1.17B
Description
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...

More about BLFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account